AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Pharma-Bio Serv, Inc.
Video analysis: PBSV
All videosNo video analysis for this stock yet. Request one from our team.
News: PBSV
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026
DORADO, PR / ACCESS Newswire / September 14, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and nine months ended July 31, 2026 were approximately $2.3 million and $7.3 million, respectively, representing increases of approximately $0.4 million and $0.5 million compared to the same periods last year. For the three and nine months ended July 31, 2026, the Company reported a net loss of $14 thousand and net income of approximately $252 thousand, respectively, representing improvements of approximately $190 thousand and $352 thousand, respectively, compared with the corresponding periods of the prior year.
Pharma-Bio Serv (OTCMKTS:PBSV) Share Price Crosses Below 200 Day Moving Average – Should You Sell?
Pharma-Bio Serv Inc. (OTCMKTS:PBSV - Get Free Report) shares passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.53 and traded as low as $0.4225. Pharma-Bio Serv shares last traded at $0.4225, with a volume of 100 shares changing hands. Pharma-Bio Serv Trading Down 21.7%
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026
DORADO, PR / ACCESS Newswire / June 15, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and six months ended April 30, 2026 were approximately $2.7 million and $5.0 million, respectively, representing increases of approximately $0.3 million and $0.1 million compared to the same periods last year. Net income for the three and six months ended April 30, 2026, was approximately $0.2 million and $0.3 million, respectively, representing increases of approximately $0.1 million and $0.2 million compared to the same periods last year.
Similar companies
-
PreAxia Health Care Payment Systems Inc.
PAXH
·
Other OTC
Compare
-
Vynleads, Inc.
VYND
·
Other OTC
Compare
-
VentriPoint Diagnostics Ltd.
VPTDF
·
Other OTC
Compare
-
Sirona Biochem Corp.
SRBCF
·
Other OTC
Compare
-
SpotLite360 IOT Solutions, Inc.
SPLTF
·
Other OTC
Compare
-
Unidoc Health Corp.
UDOCF
·
Other OTC
Compare